May 4, 2017 / 11:20 AM / 3 months ago

BRIEF-Intercept Pharmaceuticals Qtrly total revenue $21.0 mln

May 4 (Reuters) - Intercept Pharmaceuticals Inc:

* Intercept Pharmaceuticals reports first quarter 2017 financial results and provides business update

* Qtrly total revenue $ 21.0 million versus $ 445,000

* Qtrly net loss per common and potential common share $ 3.61

* Intercept pharmaceuticals - continues to project non-gaap adjusted operating expenses of $380 million to $420 million for fiscal year ending december 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below